🟢 Cue Biopharma is trading 5% up in pre-market on continued biotech-sector momentum

Cue Biopharma is trading 5.09% up now at $30.32, after extending gains from August 25 and August 26, with continued biotechnology-sector momentum cited as the strongest driver.

• No new company-specific announcement dated August 27 was identified; XBI gained 2.06% during the August 26 session.
• Broader risk appetite is supportive, with Nasdaq futures up 1.13%, helped by Nvidia’s upbeat outlook.